COMPASS Pathways (CMPS) Stock Soars 25% on Trump’s Psychedelics Research Order

COMPASS Pathways (CMPS) stock jumped 25% after Trump's executive order on psychedelic research. Positive Phase 3 data boosts investor confidence.

The post COMPASS Pathways (CMPS) Stock Soars 25% on Trump’s Psychedelics Research Order appeared first on Blockonomi.